1Ritchie K,Kildea D.Is senile dementia "age-related" or "aging-related"? Evidence from meta-analysis of dementia prevalence in the oldest old.Lancet 1995.346:931-934.
2Ebly E,Hogan D,Parhad I,Cognitive Impairment in the non-demented elderly.Results from the Canadian study of health and aging.Arch Neurol 1995.52:612-619.
3Bondi M,Monsch A,Galasko D et al.Preclinical cognitive markers of dementia of the Alzheimer's type.Neuropsychology 1994.8:374-384.
4Flicker C,Ferris S,Reisberg B,A two-year longitudmal study of cognitive function in normal aging and Alzheimer's disease.J Geriatr Psychiatry Nenrol 1993.6:84-96.
5La Rue A.Javik L.Cognitive function and prediction of dementia in old age.Int J Aging Hum Dev 1987.25:79-89.
6Jacobs D,Sano M,Dooneief G et al.Neuropsychological detection and characterization of preclinical Alzhemer's disease.Neurology 1995.45:957-962.
7Hom J.Turner M.Risser R et al.Cognitive deficits in asymptomatic first degree relatives of Alzheimer's disease patients.J Clin Exp Neuropsychol 1994.16:568-576.
8La Rue A,Matsuyama S.McPherson S et al.Cognitive performance in relatives of patients with probable Alzhermer discase,An age at onset effect J Clin Exp Neuropsychol 1992.14:533-538.
9Newman S,Warrington E,Kennedy A,Rossor M.The earliest cognitive change in a person with familial Alzhemer's disease.Presymptomatic neuro-psychological fcatures in a pedigree with familial Alzhedimer's disease confirmed at necropsy.J Neurol Neurosurg Psychatry 1994.57:967-972.
10Smalley S,Wolkenstein B,La Rue A et al.Commingling analysis of memory performance in offspring of Alzbeimer patients.Gener Epidemiol 1992.9:333-345.
2Petersen RC. Mild cognitive impairment: transition between aging and Alzheimer' s disease. Neurologia. 2000; 15(3): 93-101.
3Ritchie K, Touchon J. Mild cognitive impairment: conceptual basis and current nosological status. Lancet. 2000; 355(9199): 225 228.
4Hanninen T, Hallikainen M, Tuomainen S, Vanhanen M, Soininen H. Prevalence of mildcognitive impairment; a population based study in elderly subjects. Acta Neurol Scand. 2002; 106(3); 148-154.
5Petersen RC, Smith GE, Waring SC. Ivnik R3, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Nerol. 1999, 56 (3) : 303- 308.
6Busse A, Bischkopf J, Riedel-Heller SG, Angermeyer MC. Subclassifications for mild cognitive impairment: prevalence and predictive validity. Psychol Med. 2003; 33(6) : 1029-1038.
7Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeifer E, Sano M, van Dyck CH, Thal LJ; Alzheimer's Disease Cooperative Study Group. Vitamin E and donepezil for the treatment of mild cognitive im pairment. N EnglJ Med. 2005; 352(23): 2379-2388.
8Clinical trial: Institute on Aging. Memory impairment study (mild cognitive impairment study)[2007-05-24]. http ://clinicaltrials. gov/ct2/show/NCTO0000173.
9Clinical trial: Nicotine treatment of mild cognitive im pairment [2007-05-24]. http://clinicaltrials, gov/ct2/ show/NCT000914687 order= 1.
10McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurolo gy. 1984; 34(7) : 939- 944.
